136 related articles for article (PubMed ID: 16764927)
1. beta2 Integrins are characteristically absent in acute promyelocytic leukemia and rapidly upregulated in vivo upon differentiation with all-trans retinoic acid.
Wu JJ; Cantor A; Moscinski LC
Leuk Res; 2007 Jan; 31(1):49-57. PubMed ID: 16764927
[TBL] [Abstract][Full Text] [Related]
2. Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia.
Cunha De Santis G; Tamarozzi MB; Sousa RB; Moreno SE; Secco D; Garcia AB; Lima AS; Faccioli LH; Falcão RP; Cunha FQ; Rego EM
Haematologica; 2007 Dec; 92(12):1615-22. PubMed ID: 18055984
[TBL] [Abstract][Full Text] [Related]
3. Selective up-regulation of phospholipase C-beta2 during granulocytic differentiation of normal and leukemic hematopoietic progenitors.
Bertagnolo V; Marchisio M; Pierpaoli S; Colamussi ML; Brugnoli F; Visani G; Zauli G; Capitani S
J Leukoc Biol; 2002 Jun; 71(6):957-65. PubMed ID: 12050180
[TBL] [Abstract][Full Text] [Related]
4. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
Randolph TR
Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid down-regulates expression and function of beta2 integrins by human monocytes: opposite effects on monocytic cell lines.
Babina M; Henz BM
Eur J Immunol; 2003 Mar; 33(3):616-25. PubMed ID: 12616482
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemia.
Rice AM; Holtz KM; Karp J; Rollins S; Sartorelli AC
Leuk Res; 2004 Nov; 28(11):1227-37. PubMed ID: 15380350
[TBL] [Abstract][Full Text] [Related]
7. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
Cimino G; Lo-Coco F; Fenu S; Travaglini L; Finolezzi E; Mancini M; Nanni M; Careddu A; Fazi F; Padula F; Fiorini R; Spiriti MA; Petti MC; Venditti A; Amadori S; Mandelli F; Pelicci PG; Nervi C
Cancer Res; 2006 Sep; 66(17):8903-11. PubMed ID: 16951208
[TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukemia (AML-M3)--Part 1: Pathophysiology, clinical diagnosis, and differentiation therapy.
Randolph TR
Clin Lab Sci; 2000; 13(2):98-105. PubMed ID: 11066455
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid syndrome: a review.
Patatanian E; Thompson DF
J Clin Pharm Ther; 2008 Aug; 33(4):331-8. PubMed ID: 18613850
[TBL] [Abstract][Full Text] [Related]
11. Analysis of telomerase activity and RNA expression in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid.
Akiyama M; Yamada O; Yanagisawa T; Fujisawa K; Eto Y; Yamada H
Pediatr Blood Cancer; 2006 Apr; 46(4):506-11. PubMed ID: 15770638
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of interleukin 6, interleukin 8 and their receptors in acute promyelocytic leukemia during all-trans retinoic acid induction treatment].
Zeng H; Zhang X; Chen Z
Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):357-60. PubMed ID: 10921031
[TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias.
Barber N; Belov L; Christopherson RI
Leuk Res; 2008 Feb; 32(2):315-22. PubMed ID: 17561254
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells.
Awwad RT; Do K; Stevenson H; Fu SW; Lo-Coco F; Costello M; Campbell CL; Berg PE
Ann Hematol; 2008 Mar; 87(3):195-203. PubMed ID: 18026954
[TBL] [Abstract][Full Text] [Related]
15. Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia.
Di Noto R; Schiavone EM; Ferrara F; Manzo C; Lo Pardo C; Del Vecchio L
Leukemia; 1994 Nov; 8(11):1900-5. PubMed ID: 7967734
[TBL] [Abstract][Full Text] [Related]
16. [All-trans retinoic acid-induced erythema nodosum in acute promyelocytic leukemia].
Taguchi A; Takahashi T; Harima Y; Takemoto Y; Ando T; Nomiyama J; Matsubara A; Yujiri T; Tanizawa Y
Rinsho Ketsueki; 2005 Mar; 46(3):202-5. PubMed ID: 16447715
[TBL] [Abstract][Full Text] [Related]
17. Enhanced migration of the acute promyelocytic leukemia cell line NB4 under in vitro conditions during short-term all-trans-retinoic acid treatment.
Zang C; Liu H; Ries C; Ismair MG; Petrides PE
J Cancer Res Clin Oncol; 2000 Jan; 126(1):33-40. PubMed ID: 10641747
[TBL] [Abstract][Full Text] [Related]
18. Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis.
Graf M; Reif S; Kröll T; Hecht K; Nuessler V; Schmetzer H
Am J Hematol; 2006 Apr; 81(4):227-35. PubMed ID: 16550517
[TBL] [Abstract][Full Text] [Related]
19. Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia.
Di Noto R; Schiavone EM; Ferrara F; Manzo C; Lo Pardo C; Del Vecchio L
Leukemia; 1994; 8 Suppl 2():S71-6. PubMed ID: 7815843
[TBL] [Abstract][Full Text] [Related]
20. Changes in expression of WT1 isoforms during induced differentiation of the NB4 cell line.
Gu W; Chen Z; Hu S; Shen H; Qiu G; Cao X
Haematologica; 2005 Mar; 90(3):403-5. PubMed ID: 15749674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
